As of 2026-03-15, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (27.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.59 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -192.4%.
The range of the Relative Valuation is (26.47) - (29.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 19.9x | 18.8x |
| Forward P/E multiples | 16.7x - 19.8x | 18.5x |
| Fair Price | (26.47) - (29.08) | (27.34) |
| Upside | -189.5% - -198.3% | -192.4% |
| Date | P/E |
| 2026-03-12 | -20.43 |
| 2026-03-11 | -21.14 |
| 2026-03-10 | -19.99 |
| 2026-03-09 | -19.55 |
| 2026-03-06 | -18.98 |
| 2026-03-05 | -19.37 |
| 2026-03-04 | -19.70 |
| 2026-03-03 | -19.65 |
| 2026-03-02 | -20.26 |
| 2026-02-27 | -20.77 |
| 2026-02-26 | -20.23 |
| 2026-02-25 | -20.55 |
| 2026-02-24 | -21.09 |
| 2026-02-23 | -20.53 |
| 2026-02-20 | -20.00 |
| 2026-02-19 | -20.13 |
| 2026-02-18 | -20.57 |
| 2026-02-17 | -20.52 |
| 2026-02-13 | -20.47 |
| 2026-02-12 | -20.72 |
| 2026-02-11 | -20.92 |
| 2026-02-10 | -21.15 |
| 2026-02-09 | -20.64 |
| 2026-02-06 | -19.85 |
| 2026-02-05 | -18.55 |
| 2026-02-04 | -19.42 |
| 2026-02-03 | -20.23 |
| 2026-02-02 | -19.71 |
| 2026-01-30 | -19.20 |
| 2026-01-29 | -19.63 |
| 2026-01-28 | -19.57 |
| 2026-01-27 | -20.03 |
| 2026-01-26 | -19.12 |
| 2026-01-23 | -19.52 |
| 2026-01-22 | -20.32 |
| 2026-01-21 | -19.95 |
| 2026-01-20 | -19.60 |
| 2026-01-16 | -18.69 |
| 2026-01-15 | -18.15 |
| 2026-01-14 | -19.22 |
| 2026-01-13 | -17.02 |
| 2026-01-12 | -16.46 |
| 2026-01-09 | -16.99 |
| 2026-01-08 | -17.03 |
| 2026-01-07 | -16.83 |
| 2026-01-06 | -15.65 |
| 2026-01-05 | -16.08 |
| 2026-01-02 | -16.20 |
| 2025-12-31 | -16.93 |
| 2025-12-30 | -16.74 |